Enhanced antitumor effect of doxorubicin through active-targeted nanoparticles in doxorubicin-resistant triple-negative breast cancer

Keyphrases

• Active Target 100%
• Active Targeting Nanoparticles 25%
• Anticancer Effect 25%
• Antitumor Activity 25%
• Arginine 75%
• Biopolymers 25%
• Breast Cancer 25%
• Cancer Cells 25%
• Cancer Treatment 25%
• Chemotherapy 50%
• Clinical Cancer 25%
• Common Cancers 25%
• Doxorubicin 100%
• Doxorubicin Drug 25%
• Doxorubicin-loaded 50%
• Doxorubicin-resistant 100%
• Electrostatic Force 25%
• Enhanced Efficacy 100%
• Female Cancer 25%
• Fucoidan 75%
• Gelatin 25%
• Gelatin Nanoparticles 50%
• High Drug Loading 25%
• In Vitro Experiments 25%
• Incidence Rate 25%
• Mortality Rate 25%
• Multidrug Resistance 25%
• Multidrug-resistant 25%
• Nanocarriers 25%
• Nanoparticle Drug Delivery System 25%
• Nanoparticles 75%
• P-selectin 25%
• PH-responsive 25%
• Potential Therapeutic Strategies 25%
• Responsive Characteristics 25%
• Targeted Nanoparticles 100%
• Treatment Strategy 25%
• Triple-negative Breast Cancer 100%
• Triple-negative Breast Cancer Cells 25%
• Tumor Site 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiinfective Agent 33%
• Antitumor Activity 16%
• Arginine 50%
• Biopolymer 16%
• Breast Cancer 16%
• Chemotherapy Regimens 33%
• Doxorubicin 100%
• Drug Delivery System 16%
• Fucoidan 50%
• Gelatin 50%
• Malignant Neoplasm 50%
• Mortality Rate 16%
• Multidrug Resistance 16%
• Nanocarrier 16%
• Nanoparticle 100%
• Nanoparticle Drug Delivery 16%
• Neoplasm 16%
• P-Selectin 16%
• Triple Negative Breast Cancer 100%